XOMA Corp.
(NASDAQ : XOMA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -1.24%63.151.0%$510.50m
AMGNAmgen, Inc. -4.02%225.591.3%$451.51m
BIIBBiogen, Inc. -2.14%278.141.4%$375.15m
ILMNIllumina, Inc. -2.27%319.583.5%$322.74m
VRTXVertex Pharmaceuticals, Inc. -2.07%229.061.9%$273.01m
REGNRegeneron Pharmaceuticals, Inc. -3.17%345.282.6%$238.76m
EXASEXACT Sciences Corp. -2.83%89.5724.0%$223.37m
ALXNAlexion Pharmaceuticals, Inc. -3.02%105.272.0%$170.84m
AAgilent Technologies, Inc. -0.92%88.251.6%$130.79m
INCYIncyte Corp. -1.92%76.742.5%$127.16m
BMRNBioMarin Pharmaceutical, Inc. 0.61%86.154.3%$108.27m
SRPTSarepta Therapeutics, Inc. -1.14%112.3914.6%$108.00m
SGENSeattle Genetics, Inc. -1.54%113.576.1%$103.89m
BLUEbluebird bio, Inc. -2.74%87.2614.2%$86.40m
DERMDermira, Inc. -0.27%18.713.8%$83.32m

Company Profile

XOMA Corp. engages in the discovery and development of innovative therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.